Literature DB >> 16198509

Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy.

Alexandra Taylor1, Andrea G Rockall, Rodney H Reznek, Melanie E B Powell.   

Abstract

PURPOSE: To establish guidelines for delineating the clinical target volume for pelvic nodal irradiation by mapping the location of lymph nodes in relation to the pelvic anatomy. METHODS AND MATERIALS: Twenty patients with gynecologic malignancies underwent magnetic resonance imaging with administration of iron oxide particles. All visible lymph nodes were outlined. Five clinical target volumes were generated for each patient using modified margins of 3, 5, 7, 10, and 15 mm around the iliac vessels. The nodal contours were then overlaid and individual nodes analyzed for coverage. The volume of normal tissue within each clinical target volume and planning target volume was also measured to aid selection of the margin that could provide maximal nodal, but minimal normal tissue, coverage.
RESULTS: In total, 1216 nodal contours were evaluated. The nodal coverage was 56%, 76%, 88%, 94%, and 99% using vessel margins of 3, 5, 7, 10, and 15 mm, respectively. The mean volume of bowel within the planning target volume was 146.9 cm3 with a 7-mm margin, 190 cm3 with a 10-mm margin, and 266 cm3 with a 15-mm margin. Minor modification to the 7-mm margin ensured 99% coverage of the pelvic nodes.
CONCLUSION: Blood vessels with a modified 7-mm margin offer a good surrogate target for pelvic lymph nodes. By making appropriate adjustments, coverage of specific nodal groups may be increased and the volume of normal tissue irradiated decreased. On the basis of these findings, recommended guidelines for outlining pelvic nodes have been produced.

Entities:  

Mesh:

Year:  2005        PMID: 16198509     DOI: 10.1016/j.ijrobp.2005.05.062

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  65 in total

1.  Repeat CT-scan assessment of lymph node motion in locally advanced cervical cancer patients.

Authors:  Luiza Bondar; Laura Velema; Jan Willem Mens; Ellen Zwijnenburg; Ben Heijmen; Mischa Hoogeman
Journal:  Strahlenther Onkol       Date:  2014-08-27       Impact factor: 3.621

2.  Evaluation of pelvic lymph node coverage of conventional radiotherapy fields based on bony landmarks in Chinese cervical cancer patients using CT simulation.

Authors:  Xiang Zhang; Hua Yu
Journal:  J Zhejiang Univ Sci B       Date:  2009-09       Impact factor: 3.066

3.  Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.

Authors:  Jen-Yu Cheng; Eng-Yen Huang; Shun-Neng Hsu; Chong-Jong Wang
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

Review 4.  [Clinical target volume : Principles and limits].

Authors:  T B Brunner; M Walke; P Hass
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

5.  Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation.

Authors:  Katrien Vandecasteele; Wilfried De Neve; Werner De Gersem; Louke Delrue; Leen Paelinck; Amin Makar; Valérie Fonteyne; Carlos De Wagter; Geert Villeirs; Gert De Meerleer
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

Review 6.  Magnetic resonance lymphography in gynaecological malignancies.

Authors:  Noor Jahan; Priya Narayanan; Andrea Rockall
Journal:  Cancer Imaging       Date:  2010-03-16       Impact factor: 3.909

7.  Assessment of nodal target definition and dosimetry using three different techniques: implications for re-defining the optimal pelvic field in endometrial cancer.

Authors:  Susan Guo; Ronald D Ennis; Stephen Bhatia; Frieda Trichter; Benjamin Bashist; Jinesh Shah; Manjeet Chadha
Journal:  Radiat Oncol       Date:  2010-06-27       Impact factor: 3.481

8.  Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer.

Authors:  Sabine Vieillot; David Azria; Claire Lemanski; Carmen Llacer Moscardo; Sophie Gourgou; Jean-Bernard Dubois; Norbert Aillères; Pascal Fenoglietto
Journal:  Radiat Oncol       Date:  2010-10-13       Impact factor: 3.481

9.  Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy.

Authors:  Larissa J Lee; Cheryl A Sadow; Anthony Russell; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-13       Impact factor: 7.038

10.  Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer.

Authors:  Valerie K Reed; Jose L Cavalcanti; Eric A Strom; George H Perkins; Julia L Oh; Welela Tereffe; Tse-Kuan Yu; Henry Yeung; Gary J Whitman; Isabelle Bedrosian; Homer A Macapinlac; Thomas A Buchholz; Wendy A Woodward
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.